Structured Tailored Rehabilitation After Hip Fragility Fracture
STRATIFY
1 other identifier
interventional
60
1 country
1
Brief Summary
Why the investigators are doing this study? The best approach to rehabilitation after a broken hip is not known. A new approach could improve outcomes by tailoring rehabilitation to patient needs. This approach identifies subgroups of patients within a population who have different risks of poor outcomes. These subgroups are then matched to treatments better tailored to their needs. Survivors of a broken hip describe a tailored approach as key to recovery. Further, the NHS recommends this approach as central to healthcare progress. This study wants to see if it is possible for the NHS to deliver this new approach to rehabilitation for older adults who break their hip. What will be done? The investigators worked with patients to plan this study. Patients will keep helping the investigators during the study. Sixty older people who had surgery to fix a broken hip will be invited to take part. Participants will be given a level of risk (low, medium, or high) based on an online calculator (www.stratifyhip.co.uk). All 60 participants will get usual care provided locally. Half, selected by chance, will get extra rehabilitation during their hospital stay including a self-managed exercise programme for the low-risk subgroup, education, a goal-orientated mobility programme and enhanced discharge planning for the medium-risk subgroup, and education, a goal-orientated activity of daily living programme, orientation, and enhanced assessment for the high-risk subgroup. The investigators will collect information from the 60 people taking part, at the beginning, middle, and end of the study and again 12- weeks later. What will the next step be? If this small study shows this extra rehabilitation can be provided in the NHS, and it may help patients, then the investigators plan to do a larger study. The larger study will see if this extra rehabilitation works to help older people get back home and feel happier.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2023
CompletedFirst Posted
Study publicly available on registry
August 28, 2023
CompletedStudy Start
First participant enrolled
April 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedJuly 29, 2024
July 1, 2024
10 months
August 18, 2023
July 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Treatment fidelity (supervised intervention)
measured through assessment of treatment logs
At the end of the intervention when the participant is discharged from the ward (average length of inpatient stay is 16 days)
Treatment fidelity (unsupervised intervention)
measured through assessment of patient diary
At the end of the intervention when the participant is discharged from the ward (average length of inpatient stay is 16 days)
Secondary Outcomes (17)
Count of screened, eligibly, approached, recruited and retained participants
screening through to 12-week follow-up
Acceptability of intervention to participants, carers and therapists
At the end of the intervention when the participant is discharged from the ward (average length of inpatient stay is 16 days)
Barriers and enablers to intervention delivery
At the end of the intervention when the participant is discharged from the ward (average length of inpatient stay is 16 days)
Acceptability and completeness of EuroQoL EQ-5D-5L
Baseline, at the end of the intervention when the participant is discharged from the ward (average length of inpatient stay is 16 days), and 12-week follow-up
Acceptability and completeness of Barthel Index
Baseline, at the end of the intervention when the participant is discharged from the ward (average length of inpatient stay is 16 days), and 12-week follow-up
- +12 more secondary outcomes
Study Arms (2)
Stratify
EXPERIMENTALPatients randomised to the 'Stratify' intervention will receive usual care and an intervention based on their subgroup assignment. The intervention will start before the third postoperative day and be delivered during the inpatient stay. Intervention components will be delivered by a physiotherapist, occupational therapist, or therapy assistant depending on staffing availability.
Usual care
PLACEBO COMPARATORPatients randomised to the control arm will receive usual physiotherapy and occupational therapy care.
Interventions
Education, goal-orientated mobility programme, and enhanced discharge planning.
Education, enhanced assessment, orientation, and goal-orientated activities of daily living training programme.
Usual care entails physiotherapy and occupational therapy from the day after surgery to the point of discharge, with a focus on discharge planning and sufficient recovery of activities of daily living and mobility for safe return to prefracture residence.
Eligibility Criteria
You may qualify if:
- aged 60 years or more.
- admitted to hospital for surgical repair of a hip fracture.
- who are willing and able to provide consent or assent depending on the level of cognitive impairment.
You may not qualify if:
- less than 60 years, to align with the National Hip Fracture Databases definition of the target population.
- not surgically treated, as this treatment approach is reserved for around 2% of patients in the UK who are often at the end of life.
- who broke their hip in hospital following admission for a different illness/injury as their anticipated care pathway and outcomes will vary from those who are admitted for hip fracture.
- participating in other treatment trials and without agreement of both trial teams.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- King's College Londonlead
- UK Research and Innovationcollaborator
Study Sites (1)
St Thomas Hospital
London, United Kingdom
Related Publications (1)
Sheehan KJ, Guerra S, Ayis S, Goubar A, Foster NE, Martin FC, Godfrey E, Cameron ID, Gregson CL, Walsh NE, Ferguson Montague A, Edwards R, Adams J, Jones GD, Gibson J, Sackley C, Whitney J. Structured tailored rehabilitation after hip fragility fracture: The 'Stratify' feasibility and pilot randomised controlled trial protocol. PLoS One. 2024 Dec 17;19(12):e0306870. doi: 10.1371/journal.pone.0306870. eCollection 2024.
PMID: 39689129DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 18, 2023
First Posted
August 28, 2023
Study Start
April 15, 2024
Primary Completion
January 30, 2025
Study Completion
June 1, 2025
Last Updated
July 29, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Following publication of the primary paper, an anonymised dataset will be preserved indefinitely on the King's Open Research Data System.
- Access Criteria
- Proof of ethical approval as a condition of access.
An anonymised dataset will be preserved on the King's Open Research Data System. This dataset will include anonymised data collected which does not breach any agreement for outcome measure use.